Showing results (41-50 of 75) with videos related to
Sort By:
Pageof 8
Nature|April 1, 2021
Structural basis of malaria RIFIN binding by LILRB1-containing antibodiesYiwei Chen, Kai Xu, Luca Piccoli, et al.Nature Communications|July 10, 2021
Structural basis of LAIR1 targeting by polymorphic Plasmodium RIFINsKai Xu, Yiran Wang, Chen-Hsiang Shen, et al.European Journal of Immunology|March 8, 2018
Variable domain N-linked glycosylation and negative surface charge are key features of monoclonal ACPA: Implications for B-cell selectionKaty A Lloyd, Johanna Steen, Khaled Amara, et al.Nature Medicine|September 11, 2019
A single T cell epitope drives the neutralizing anti-drug antibody response to natalizumab in multiple sclerosis patientsAntonino Cassotta, Vincent Mikol, Thomas Bertrand, et al.Nature|December 25, 2015
A LAIR1 insertion generates broadly reactive antibodies against malaria variant antigensJoshua Tan, Kathrin Pieper, Luca Piccoli, et al.The Lancet Regional Health. Europe|June 26, 2021
Risk assessment and seroprevalence of SARS-CoV-2 infection in healthcare workers of COVID-19 and non-COVID-19 hospitals in Southern SwitzerlandLuca Piccoli, Paolo Ferrari, Giovanni Piumatti, et al.Nature|August 29, 2017
Public antibodies to malaria antigens generated by two LAIR1 insertion modalitiesKathrin Pieper, Joshua Tan, Luca Piccoli, et al.Nature Medicine|March 20, 2018
A public antibody lineage that potently inhibits malaria infection through dual binding to the circumsporozoite proteinJoshua Tan, Brandon K Sack, David Oyen, et al.Acta Neuropathologica|March 28, 2021
Single-cell profiling of myasthenia gravis identifies a pathogenic T cell signatureFlorian Ingelfinger, Sinduya Krishnarajah, Michael Kramer, et al.Cell Reports|September 3, 2020
Identification and Structure of a Multidonor Class of Head-Directed Influenza-Neutralizing Antibodies Reveal the Mechanism for Its Recurrent ElicitationCrystal Sao-Fong Cheung, Alexander Fruehwirth, Philipp Carl Georg Paparoditis, et al.Pageof 8